Amanote Research

Amanote Research

    RegisterSign In

TLR2 – An Innate Immune Checkpoint in Multiple Sclerosis

Oncotarget - United States
doi 10.18632/oncotarget.6031
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

October 8, 2015

Authors
Md Jakir HossainRadu TanasescuBruno Gran
Publisher

Impact Journals, LLC


Related search

Intricate Interplay Between Innate Immune Cells and TRMP2 in a Mouse Model of Multiple Sclerosis

Journal of Neuroscience
Neuroscience
2019English

Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

New England Journal of Medicine
Medicine
2012English

TIGIT as an Emerging Immune Checkpoint

Clinical and Experimental Immunology
AllergyImmunology
2019English

Biomarkers of the Innate and Adaptive Immune System Responsible for the Pathogenesis of Multiple Sclerosis - A Narrative Review

Open Access Journal of Neurology & Neurosurgery
2019English

A Subtype of Multiple Sclerosis Defined by an Activated Immune Defense Program

Genes and Immunity
ImmunologyGenetics
2006English

Immune Competence After Alemtuzumab Treatment of Multiple Sclerosis

Neurology
Neurology
2013English

Innate Immune Mechanisms in Myocardial Infarction - An Update

Revista Romana de Medicina de Laborator
2018English

Survive an Innate Immune Response Through XBP1

Cell Research
Cell BiologyMolecular Biology
2010English

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy